A lab experiment that simulated Mars conditions showed that green algae can grow in plastic containers made from the same ...

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for ...

US food tech startup Clever Carnivore has achieved industry-leading cost reductions for its cultivated pork, which it hopes ...

Chicago, May 21, 2025 (GLOBE NEWSWIRE) -- The global medical bioreactor market was valued at US$ 4.31 billion in 2024 and is expected to reach US$ 7.04 billion by 2033, growing at a CAGR of 5.80% ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations such as the launch of large-scale single-use bioreactors, demand from ...

Biopharmaceutical companies don’t have to stick to a single bioreactor design during scale-up. That’s according to Stefan Junne, PhD, an associate professor at Aalborg University.

CytoImmune Therapeutics boasts a team of pioneers in bioreactor design, with extensive experience in applying computational fluid dynamics for optimizing reactor applications ranging from peptides ...

Hemostemix's Strategic Advantages from CytoImmune's Bioreactor Technologies License Lowest cost of goods sold for allogenic products. Strategic fence around autologous stem cell production.

Biosphere’s proprietary UV-enabled design simplifies bioreactor hardware, eliminating the need for expensive and complex infrastructure and delivering 10x the production capacity with the same ...

About Biosphere Founded in 2022 and based in Oakland, CA, Biosphere is at the forefront of revolutionizing modern bioreactor design. Backed by world-class investors including B37 Ventures, Caffeinated ...